enVVeno Medical Corporation
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
enVVeno Medical Corporation is a medical device company focused on developing bioprosthetic, tissue-based solutions for venous disease. The company’s current portfolio centers on the VenoValve, a surgical replacement venous valve designed for patients with deep venous chronic venous insufficiency, and enVVe, a non-surgical, transcatheter-based venous valve system under development. These products are intended to address valve failure in the deep venous system and support more effective blood flow in patients with chronic venous disorders. enVVeno Medical Corporation serves the broader vascular medicine market, where it aims to improve treatment options for conditions that can cause pain, swelling, and long-term circulatory problems. Based in Irvine, California and incorporated in 1999, the company remains a late clinical-stage player in specialized medical technology, with a business model centered on advancing implantable and minimally invasive venous care solutions.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Robert A. Berman
- Employees
- 37
- Headquarters
- Irvine, CA, United States
- Website
- www.envveno.com